info@invisionmedi.com
V-BOSE-GM2 – Tablets
An Abiding Antidiabetic combination for coherent Diabetic Control
COMPOSITION – Glimepiride IP 2 mg+ Voglibose 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)
Description
Glimepiride
» A medium-to-long acting sulfonylurea anti-diabetic drug that exhibits a high potency.
» Improves insulin resistance in hyperinsulinemic patients.
Voglibose
» Categorized under the class of Alpha-glucosidase inhibitor used in the management of type 2 diabetes.
» Used for lowering post-prandial blood glucose levels in people with diabetes mellitus.
Combination
- Triple drug combination is safe and effective in patients with type 2 diabetes.
Composition
Glimepiride IP 2 mg+ Voglibose 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)
Related products
-
V-BOSE-0.2/ 0.3 Tablets
Limiting Hyperglycemia without Compromising Hypoglycemia COMPOSITION – Voglibose IP 0.2 Voglibose IP 0.3
-
ZIVALIO-M 500ER Tablets
For better Diabetic Outcomes COMPOSITION – Zivalio-M 500 ER Dapagliflozin 10mg + Metformin HCL IP 500mg Tablets
-
TENLIFAST-M 500SR / 1000SR Tablets
Prevent Diabetic Complications & Acquire Functional Hemodynamic Indices COMPOSITION – Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20 mg + Metformin Hydrochloride IP 500 mg (SR) Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20 mg + Metformin Hydrochloride IP 1000 mg (SR)
-
REVOSART-A Tablets
A single-pill combination with a promising clinical impact on hypertension COMPOSITION – Telmisartan 40 mg + Amlodipine Besilate 5 mg